Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?-Reference-Cited by-同舟云学术

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?

Published:2018-03 Issue:1 Volume:17 Page:e109-e113
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Ibrahim Sajida,Girault Alban,Ohresser Marc,Lereclus Emilie,Paintaud Gilles,Lecomte Thierry,Raoul William^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference67 articles.

1. Survival of cancer patients in France: a population-based study from the Association of the French Cancer Registries (FRANCIM);Bossard;Eur J Cancer,2007

2. Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010;Jooste;Eur J Cancer Prev,2011

3. Worldwide burden of colorectal cancer: a review;Favoriti;Updates Surg,2016

4. Current and advancing treatments for metastatic colorectal cancer;Sanz-Garcia;Expert Opin Biol Ther,2016

5. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance;Boehm;Nature,1997

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IL-17 in the pathogenesis and treatment of glioblastoma—an update on the state of the art and future perspectives;Medical Oncology;2024-06-25

2. Anti‐angiogenesis in colorectal cancer therapy;Cancer Science;2024-01-17

3. Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL‐17 expression associated with cancer relapse;International Journal of Cancer;2023-10-03

4. Molecular mechanisms of long non-coding RNAs in differentiation of T Helper17 cells;International Immunopharmacology;2023-10

5. The roles of lncRNAs in Th17-associated diseases, with special focus on JAK/STAT signaling pathway;Clinical and Experimental Medicine;2023-09-24